List of works - Kirstine N Bojsen-Møller

Accelerated protein digestion and amino acid absorption after Roux-en-Y gastric bypass

Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance

scientific article published on 24 April 2012

Augmented GLP-1 Secretion as Seen After Gastric Bypass May Be Obtained by Delaying Carbohydrate Digestion

scientific article published on 01 August 2019

Bilio-enteric flow and plasma concentrations of bile acids after gastric bypass and sleeve gastrectomy

scientific article published on 21 April 2020

Chenodeoxycholic acid stimulates glucagon-like peptide-1 secretion in patients after Roux-en-Y gastric bypass.

scientific article published on 14 February 2017

Circulating Glucagon 1-61 Regulates Blood Glucose by Increasing Insulin Secretion and Hepatic Glucose Production

scientific article published in November 2017

Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass

scientific article published on 15 November 2013

Effect of bariatric surgery on plasma GDF15 in humans

scientific article published on 05 February 2019

Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery

Effects of gastric bypass surgery on glucose absorption and metabolism during a mixed meal in glucose-tolerant individuals

scientific article published on 27 July 2013

Emerging drugs for the treatment of obesity.

scientific article published on 7 December 2016

Enhanced insulin signaling in human skeletal muscle and adipose tissue following gastric bypass surgery

scientific article published on 10 June 2015

Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes.

scientific article published on 06 May 2013

Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass

scientific article

Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux-en-Y gastric bypass

article

GLP-2 and GIP exert separate effects on bone turnover: A randomized, placebo-controlled, crossover study in healthy young men

scientific article published on 15 May 2019

Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass.

scientific article published on 19 February 2013

Hepatic Insulin Clearance in Regulation of Systemic Insulin Concentrations-Role of Carbohydrate and Energy Availability

Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?

scientific article published on 03 June 2014

Immediate enhancement of first-phase insulin secretion and unchanged glucose effectiveness in patients with type 2 diabetes after Roux-en-Y gastric bypass

scientific article published on 27 January 2015

Improvements in glucose metabolism early after gastric bypass surgery are not explained by increases in total bile acids and fibroblast growth factor 19 concentrations

scientific article published on 23 December 2014

In vivo and in vitro degradation of peptide YY3-36 to inactive peptide YY3-34 in humans

scientific article published on 27 January 2016

Increased hepatic insulin clearance after Roux-en-Y gastric bypass.

scientific article

Intestinal sensing and handling of dietary lipids in gastric bypass-operated patients and matched controls

scientific article published on 01 January 2020

Mechanisms Preserving Insulin Action during High Dietary Fat Intake

scientific article published on 27 September 2018

Mechanisms Preserving Insulin Action during High Dietary Fat Intake

scientific article published on 01 January 2019

Mechanisms Underlying Absent Training-Induced Improvement in Insulin Action in Lean, Hyperandrogenic Women With Polycystic Ovary Syndrome (PCOS)

scientific article published on 01 September 2020

Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss.

scientific article published on 8 March 2018

Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass

scientific article published on April 2015

No Islet Cell Hyperfunction, but Altered Gut-Islet Regulation and Postprandial Hypoglycemia in Glucose-Tolerant Patients 3 Years After Gastric Bypass Surgery.

scientific article

No effects of a six-week intervention with glucagon-like peptide-1 receptor analogue on pancreatic volume and edema in obese men without diabetes

scientific article published on 04 June 2020

Nutrient re-routing and altered gut-islet cell crosstalk may explain early relief of severe postprandial hypoglycaemia after reversal of Roux-en-Y gastric bypass.

scientific article published on 7 August 2017

Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.

scientific article published on 30 August 2016

Plasma Proteome Profiling Reveals Dynamics of Inflammatory and Lipid Homeostasis Markers after Roux-En-Y Gastric Bypass Surgery

scientific article published on 05 December 2018

Postprandial Nutrient Handling and Gastrointestinal Hormone Secretion After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy

scientific article published on 08 February 2019

Pros and cons of Roux en-Y gastric bypass surgery in obese patients with type 2 diabetes

scientific article published on 19 June 2019

Reduction in cardiovascular risk factors and insulin dose, but no beta-cell regeneration 1 year after Roux-en-Y gastric bypass in an obese patient with type 1 diabetes: a case report

scientific article published in July 2013

Responses of gut and pancreatic hormones, bile acids, and fibroblast growth factor-21 differ to glucose, protein, and fat ingestion after gastric bypass surgery

scientific article published on 18 February 2020

Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota

scientific article

Secretin release after Roux-en-Y gastric bypass reveals a population of glucose-sensitive S cells in distal small intestine

scientific article published on 03 February 2020

Sustained Improvements in Glucose Metabolism Late After Roux-En-Y Gastric Bypass Surgery in Patients with and Without Preoperative Diabetes

scientific article published on 22 October 2019

Systems Signatures Reveal Unique Remission-path of Type 2 Diabetes Following Roux-en-Y Gastric Bypass Surgery

scientific article published on 2 February 2018

The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery

scientific article published on 17 March 2020

Updates in weight loss surgery and gastrointestinal peptides

scientific article

Variable reliability of surrogate measures of insulin sensitivity after Roux-en-Y gastric bypass

scientific article published on 15 February 2017

List of works by Kirstine N Bojsen-Møller

Accelerated protein digestion and amino acid absorption after Roux-en-Y gastric bypass

Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance

Augmented GLP-1 Secretion as Seen After Gastric Bypass May Be Obtained by Delaying Carbohydrate Digestion

Bilio-enteric flow and plasma concentrations of bile acids after gastric bypass and sleeve gastrectomy

Chenodeoxycholic acid stimulates glucagon-like peptide-1 secretion in patients after Roux-en-Y gastric bypass.

Circulating Glucagon 1-61 Regulates Blood Glucose by Increasing Insulin Secretion and Hepatic Glucose Production

Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass

Effect of bariatric surgery on plasma GDF15 in humans

Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery

Effects of gastric bypass surgery on glucose absorption and metabolism during a mixed meal in glucose-tolerant individuals

Emerging drugs for the treatment of obesity.

Enhanced insulin signaling in human skeletal muscle and adipose tissue following gastric bypass surgery

Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes.

Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass

Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux-en-Y gastric bypass

GLP-2 and GIP exert separate effects on bone turnover: A randomized, placebo-controlled, crossover study in healthy young men

Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass.

Hepatic Insulin Clearance in Regulation of Systemic Insulin Concentrations-Role of Carbohydrate and Energy Availability

Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?

Immediate enhancement of first-phase insulin secretion and unchanged glucose effectiveness in patients with type 2 diabetes after Roux-en-Y gastric bypass

Improvements in glucose metabolism early after gastric bypass surgery are not explained by increases in total bile acids and fibroblast growth factor 19 concentrations

In vivo and in vitro degradation of peptide YY3-36 to inactive peptide YY3-34 in humans

Increased hepatic insulin clearance after Roux-en-Y gastric bypass.

Intestinal sensing and handling of dietary lipids in gastric bypass-operated patients and matched controls

Mechanisms Preserving Insulin Action during High Dietary Fat Intake

Mechanisms Preserving Insulin Action during High Dietary Fat Intake

Mechanisms Underlying Absent Training-Induced Improvement in Insulin Action in Lean, Hyperandrogenic Women With Polycystic Ovary Syndrome (PCOS)

Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss.

Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass

No Islet Cell Hyperfunction, but Altered Gut-Islet Regulation and Postprandial Hypoglycemia in Glucose-Tolerant Patients 3 Years After Gastric Bypass Surgery.

No effects of a six-week intervention with glucagon-like peptide-1 receptor analogue on pancreatic volume and edema in obese men without diabetes

Nutrient re-routing and altered gut-islet cell crosstalk may explain early relief of severe postprandial hypoglycaemia after reversal of Roux-en-Y gastric bypass.

Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.

Plasma Proteome Profiling Reveals Dynamics of Inflammatory and Lipid Homeostasis Markers after Roux-En-Y Gastric Bypass Surgery

Postprandial Nutrient Handling and Gastrointestinal Hormone Secretion After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy

Pros and cons of Roux en-Y gastric bypass surgery in obese patients with type 2 diabetes

Reduction in cardiovascular risk factors and insulin dose, but no beta-cell regeneration 1 year after Roux-en-Y gastric bypass in an obese patient with type 1 diabetes: a case report

Responses of gut and pancreatic hormones, bile acids, and fibroblast growth factor-21 differ to glucose, protein, and fat ingestion after gastric bypass surgery

Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota

Secretin release after Roux-en-Y gastric bypass reveals a population of glucose-sensitive S cells in distal small intestine

Sustained Improvements in Glucose Metabolism Late After Roux-En-Y Gastric Bypass Surgery in Patients with and Without Preoperative Diabetes

Systems Signatures Reveal Unique Remission-path of Type 2 Diabetes Following Roux-en-Y Gastric Bypass Surgery

The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery

Updates in weight loss surgery and gastrointestinal peptides

Variable reliability of surrogate measures of insulin sensitivity after Roux-en-Y gastric bypass

[Medical therapy versus bariatric surgery of obese patients with Type 2 diabetes] ⬇️